A medical weight loss evaluation reviews your weight history, health conditions, medicines, eating and activity, and may include BMI, blood pressure and lab tests.
Bring your medication list, past weight-loss attempts and any recent lab results so the physician can decide whether medication fits.
This guide walks through each part of the evaluation, from weight history and medicines to mental health, pregnancy plans and labs, and explains how eligibility and follow-up are decided.
| Evaluation domain | What may be reviewed | Why it matters |
|---|---|---|
| Weight trajectory | Timing, rate, prior stability and previous attempts | Distinguishes chronic pattern, recent driver and unintentional loss |
| Health context | Diabetes, blood pressure, sleep apnea, liver, kidney and cardiovascular history | Identifies obesity-related risk and treatment constraints |
| Medicines | Prescriptions, nonprescription products and supplements | Finds weight effects, interactions and contraindications |
| Nutrition and activity | Eating pattern, access, movement, pain and physical limitations | Shapes practical, personal support |
| Mental and reproductive health | Eating-disorder history, mood, pregnancy and fertility plans | Protects against inappropriate or conflicting treatment |
| Measurements and tests | BMI, waist context, blood pressure and selected labs | Stages risk and investigates specific causes or complications |
In this article
Who Should Get a Medical Weight Loss Evaluation?
An evaluation is most useful for adults whose weight is affecting their health or daily life. Weight-management medicines are generally considered for adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure, type 2 diabetes or sleep apnea.
It is also worth booking if repeated diets have not lasted. Even when medication turns out not to be the right fit, the visit can uncover medical drivers of weight gain and set a plan that matches your health.
Weight history, BMI and medical conditions
What does the clinician ask about weight history?
The history covers when weight changed, the rate and direction of change, major life or health events, past periods of stability and approaches already tried. Repeated regain after restrictive plans can reveal a need for a different level of support, not a failure of willpower.
Discuss what you want treatment to improve, such as mobility, blood pressure, sleep or daily life. A goal need not be limited to a scale number.
Unintentional weight loss needs investigation, especially with fever, persistent digestive symptoms or weakness. It is a different problem from seeking weight-loss treatment.
How are BMI and waist measurements used?
Body mass index relates weight to height and provides a population-level screening category. It can help identify when health risk and evidence-based treatment options deserve discussion. It does not directly measure body fat, muscle, fitness or an individual’s health.
Waist circumference can add information about central fat distribution in selected adults. Technique and population context matter. Neither measurement should become a moral label or a prediction that a person will develop a disease.
Clinicians combine measurements with blood pressure, glucose status, lipids, sleep, physical function and existing conditions. The question is how weight relates to health, not whether a number fits an aesthetic ideal.
Which medical conditions are reviewed?
The evaluation commonly covers:
- Type 2 diabetes or prediabetes
- High blood pressure and abnormal lipids
- Cardiovascular disease
- Sleep apnea
- Fatty liver disease and kidney disease
- Osteoarthritis
- Reproductive or hormonal concerns
The relevance differs by person.
Symptoms may justify a thyroid or endocrine review, but broad hormone panels are not automatic. Hypothyroidism can contribute to weight change, yet it rarely explains every aspect of severe or progressive weight gain. Clinical findings guide testing.
Sleep deserves attention because insufficient or disrupted sleep can affect appetite, energy and cardiometabolic risk. Loud snoring, witnessed pauses and daytime sleepiness can justify sleep-apnea assessment.
Medicines, eating patterns and activity
Why is the medicine list important?
Some medicines can contribute to weight gain or make weight loss harder, including selected psychiatric, diabetes, seizure, corticosteroid and hormonal treatments. Others interact with potential weight-management medications or change the risk of dehydration, low glucose or gastrointestinal effects.
The clinician needs prescriptions, over-the-counter products, vitamins, herbal products and substances obtained outside routine care. Past medicines used for weight management and unregulated products should be included with dates and reactions.
Do not stop an essential medicine to influence weight without its prescriber. The clinical response may involve an alternative, additional monitoring or acceptance of a necessary tradeoff.
What nutrition questions are asked?
A useful nutrition history describes typical meals, beverages, meal timing, hunger, fullness, snacking, cultural preferences, food access and episodes of loss of control. It avoids reducing the interview to a demand for perfect recall or a confession of bad foods.
Restrictive dieting, very low intake, purging, binge eating and fear around food require careful assessment. An active eating disorder may change the treatment pathway and justify specialized support.
Protein, fiber, hydration and micronutrient needs depend on the person’s health and plan. No universal calorie target or meal prescription fits every adult.
How are activity and physical limitations assessed?
The clinician asks about current movement, work demands, joint pain, balance, shortness of breath, cardiovascular symptoms and access to suitable activity. Exercise history helps set a feasible baseline; it is not a test of commitment.
Chest pain, fainting, unexplained severe breathlessness or major mobility limitations can require medical assessment before increasing activity. Physical therapy or other support may fit better than stock exercise advice.
Activity can benefit cardiovascular health, strength, sleep and function even when the scale changes slowly. The plan should recognize those outcomes without promising a specific amount of weight loss.
Mental health, eating disorders and pregnancy plans
What mental-health context matters?
Mood, anxiety, trauma, stress, substance use, body image and prior experiences of weight stigma can affect care. The purpose is not to blame psychology for body size. It is to identify support needs and avoid a plan that worsens an eating disorder or distress.
The clinician may ask about binge eating, compensatory behaviors and suicidal thoughts when clinically relevant. Urgent mental-health risk needs appropriate crisis or emergency care, not routine program enrollment.
Behavioral support can help with planning, cues, coping and maintenance whether or not medication becomes part of care.
Why are pregnancy and fertility plans discussed?
Pregnancy status, breastfeeding and plans to conceive can change medication eligibility and timing. Some weight-management drugs are contraindicated during pregnancy, and product labels specify discontinuation considerations before a planned pregnancy.
The clinician should know about contraception, fertility treatment and reproductive goals before prescribing. A person should not use a weight-loss medicine during pregnancy or change a reproductive medicine without the responsible clinician.
This discussion applies even when pregnancy seems unlikely. A clear plan prevents treatment goals from colliding with reproductive safety.
Lab tests and prescription eligibility
Which laboratory tests may be considered?
Testing follows medical history and examination. A1C or fasting glucose may assess diabetes; a lipid panel can describe cardiovascular risk; liver and kidney tests may establish health context and medication suitability. Thyroid testing is selected when clinically relevant.
No laboratory panel proves that someone lacks discipline or qualifies automatically for a product. Tests identify conditions, baseline safety questions and outcomes worth monitoring.
Prior results can be useful when complete reports include units, reference intervals and dates. The clinician decides whether older data remain current enough for the question.
How is medication eligibility considered?
FDA-approved weight-management medications have labeled indications that use BMI together with weight-related health conditions, age and other criteria. Meeting a numerical category does not establish eligibility for a prescription. Contraindications, interactions, pregnancy plans, prior reactions and monitoring ability still matter.
For GLP-1 receptor agonists and related products, the clinician reviews gastrointestinal history, gallbladder and pancreatic context, kidney risk from dehydration, diabetes medicines and label-specific contraindications.
Product identity and FDA status must remain exact. A drug approved for diabetes should not be presented as approved for weight management unless its specific brand and label carry that indication.
Weight-loss options, goals and follow-up
What if medication is not appropriate?
Medication is one possible component, not the definition of medical care. Nutrition support, activity planning, sleep treatment, medicine review, behavioral therapy and management of related conditions can each form part of an evidence-based plan.
Some people may need a higher level of obesity-medicine, endocrinology, bariatric, eating-disorder or surgical evaluation. Referral is not a failed evaluation; it matches complexity to appropriate expertise.
A clinician may also defer a decision until pregnancy, an active illness, an uncontrolled condition or an uncertain diagnosis is addressed.
How are goals and follow-up defined?
Goals should be measurable, clinically relevant and revisited. Weight trend may be one outcome, while blood pressure, glucose, sleep, mobility, nutrition quality, medication tolerance and quality of life provide others.
Follow-up frequency depends on treatment, risk and response. The clinician watches for adverse effects, inadequate nutrition, dehydration, mood or eating changes and interactions with diabetes or blood-pressure medicines.
A plateau does not authorize a self-directed increase. The clinician assesses adherence, tolerability, expectations, biology and whether the plan still offers more benefit than burden.
What does telehealth change?
Telehealth can support history, records and a clinical evaluation, but it does not remove the need for measurements or examination. The physician may require verified weight, blood pressure, laboratory testing or in-person assessment.
Atlas HRT coordinates the logistics. An independent Florida-licensed physician decides whether Zepbound®, Wegovy® or compounded semaglutide or tirzepatide fits, and a licensed partner pharmacy dispenses any prescription. Compounded medications are prepared by a licensed pharmacy for an individual patient and are not FDA-approved. Compounded medications are not generic versions of, and have not been shown to be equivalent to, any FDA-approved drug. Wellness consultants do not calculate eligibility from a form or promise medication.
Urgent symptoms, severe dehydration, persistent vomiting, intense abdominal pain, chest pain or new neurological symptoms require timely medical care outside routine coordination.
We think the evaluation is where good weight-loss care is won or lost. A quick questionnaire can approve a prescription, but it can miss an eating disorder, a pregnancy plan or a medicine that is driving weight gain. Taking the time up front makes everything after it safer.
Common questions
Is BMI enough to qualify for medication?
No. Label criteria, weight-related conditions, contraindications, interactions, pregnancy plans and clinical judgment all affect eligibility.
Will every evaluation include blood tests?
No. Clinicians select tests based on medical history, symptoms, existing results and the treatment questions under consideration.
Does the evaluation require a strict diet history?
It reviews eating pattern, access, preferences and disordered-eating risk. The goal is useful context, not judgment or perfect recall.
Atlas HRT Team
Reviewed by · Last reviewed September 2026Atlas HRT specializes in medical weight loss evaluations and GLP-1 treatment for adults in Florida.
Sources
- Obesity Screening, MedlinePlus
- FDA compounding questions and answers, U.S. Food and Drug Administration
- FDA concerns with unapproved GLP-1 drugs used for weight loss, U.S. Food and Drug Administration
- Zepbound prescribing information, Eli Lilly; accessed October 10, 2026
